Michael Centola, Ph.D.

Chief Executive Officer & Chief Scientific Officer

Dr. Michael Centola is an immunologist and inflammatory disease expert with over 30 years of experience in turning cutting-edge science into real-world health solutions. He earned his Ph.D. in Molecular Biology & Biochemistry and became a pioneer in translating laboratory breakthroughs into patient care. Dr. Centola helped develop the first genetic and the first molecular diagnostic test for a rheumatologic disease. He has authored over 100 scientific publications while securing numerous patents in inflammatory disease therapy and device development. An advocate for evidence-based natural medicine, he has been instrumental in applying rigorous scientific standards to herbal therapy development. Today, Dr. Centola's expertise drives Nanocur's mission to enhance the power of natural remedies. He is a coinventor of Nanocur's advanced curcumin formulation—a breakthrough that overcomes curcumin's notoriously poor bioavailability. By using a patented plant-based nanoparticle carrier (covered by US Patent 10,968,260 and WO2023023648A1), this formulation protects curcumin from stomach acid and optimizes its absorption. The result is a curcumin therapy that delivers over 100 times the bioactive potency of ordinary turmeric, offering faster, more effective benefits at an affordable cost. Under Dr. Centola's leadership, Nanocur is turning cutting-edge science into accessible wellness—making advanced natural therapies safer, more effective, and affordable.